Zimmer Biomet Holdings Total Assets 2006-2019 | ZBH

Zimmer Biomet Holdings total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Zimmer Biomet Holdings total assets for the quarter ending March 31, 2019 were $24.289B, a 10.64% decline year-over-year.
  • Zimmer Biomet Holdings total assets for 2018 were $24.127B, a 7.25% decline from 2017.
  • Zimmer Biomet Holdings total assets for 2017 were $26.014B, a 2.51% decline from 2016.
  • Zimmer Biomet Holdings total assets for 2016 were $26.684B, a 1.75% decline from 2015.
Zimmer Biomet Holdings Annual Total Assets
(Millions of US $)
2018 $24,127
2017 $26,014
2016 $26,684
2015 $27,161
2014 $9,658
2013 $9,581
2012 $9,012
2011 $8,515
2010 $8,000
2009 $7,786
2008 $7,239
2007 $6,634
2006 $5,974
2005 $5,722
Zimmer Biomet Holdings Quarterly Total Assets
(Millions of US $)
Q1 2019 $24,289
Q4 2018 $24,127
Q3 2018 $25,382
Q2 2018 $25,491
Q1 2018 $27,181
Q4 2017 $26,014
Q3 2017 $26,418
Q2 2017 $26,459
Q1 2017 $26,988
Q4 2016 $26,684
Q3 2016 $27,037
Q2 2016 $25,971
Q1 2016 $26,297
Q4 2015 $27,161
Q3 2015 $26,689
Q2 2015 $27,204
Q1 2015 $17,190
Q4 2014 $9,658
Q3 2014 $9,671
Q2 2014 $9,638
Q1 2014 $9,380
Q4 2013 $9,581
Q3 2013 $9,357
Q2 2013 $9,097
Q1 2013 $8,745
Q4 2012 $9,012
Q3 2012 $8,784
Q2 2012 $8,617
Q1 2012 $8,604
Q4 2011 $8,515
Q3 2011 $8,199
Q2 2011 $8,249
Q1 2011 $8,118
Q4 2010 $8,000
Q3 2010 $8,004
Q2 2010 $7,827
Q1 2010 $7,822
Q4 2009 $7,786
Q3 2009 $7,648
Q2 2009 $7,462
Q1 2009 $7,232
Q4 2008 $7,239
Q3 2008 $7,079
Q2 2008 $6,942
Q1 2008 $6,919
Q4 2007 $6,634
Q3 2007 $6,367
Q2 2007 $6,321
Q1 2007 $6,098
Q4 2006 $5,974
Q3 2006 $5,909
Q2 2006 $5,964
Q1 2006 $5,917
Q4 2005 $5,722
Q3 2005 $5,622
Q2 2005 $5,552
Q1 2005 $5,591
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $24.965B $7.933B
Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet Holdings, Inc., formerly known as Zimmer Holdings, Inc., is based in Warsaw, United States.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $147.856B 28.70
Medtronic (MDT) Ireland $133.874B 19.12
Stryker (SYK) United States $76.669B 27.36
Boston Scientific (BSX) United States $59.033B 28.30
Baxter (BAX) United States $41.839B 26.37
EssilorLuxottica Societe Anonyme (ESLOY) France $29.060B 0.00
Coloplast (CLPBY) Denmark $25.618B 40.90
Lonza Group Ag (LZAGY) Switzerland $24.947B 0.00
Terumo (TRUMY) Japan $23.393B 26.90
Smith & Nephew SNATS (SNN) United Kingdom $19.274B 0.00
ResMed (RMD) United States $17.745B 33.90
Canopy Growth (CGC) Canada $12.161B 0.00
Sunny Optical Technology (SNPTF) China $12.027B 0.00
Bio-Rad Laboratories (BIO) United States $9.308B 49.34
William Demant Holdings (WILYY) Denmark $7.651B 0.00
Insulet (PODD) United States $7.203B 524.78
Aurora Cannabis (ACB) Canada $7.109B 70.10
Perrigo (PRGO) Ireland $7.004B 11.84
Hill-Rom Holdings (HRC) United States $6.993B 21.20
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.325B 51.63
ICU Medical (ICUI) United States $5.135B 30.64
GW Pharmaceuticals (GWPH) United Kingdom $5.057B 0.00
Neogen (NEOG) United States $3.349B 54.45
NuVasive (NUVA) United States $2.982B 24.36
Hutchison China MediTech (HCM) China $2.925B 0.00
Agios Pharmaceuticals (AGIO) United States $2.711B 0.00
National Vision Holdings (EYE) United States $2.420B 51.57
Quidel (QDEL) United States $2.309B 23.96
Cardiovascular Systems (CSII) United States $1.598B 917.80
Aphria (APHA) $1.579B 0.00
Phibro Animal Health (PAHC) United States $1.229B 18.41
AtriCure (ATRC) United States $1.218B 0.00
VAREX IMAGING (VREX) United States $1.187B 25.19
Lantheus Holdings (LNTH) United States $1.089B 28.93
NanoString Technologies (NSTG) United States $1.056B 0.00
PetIQ (PETQ) United States $0.994B 24.14
MacroGenics (MGNX) United States $0.777B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.765B 21.47
Cerus (CERS) United States $0.758B 0.00
Quanterix (QTRX) United States $0.753B 0.00
Omeros (OMER) United States $0.750B 0.00
TG Therapeutics (TGTX) United States $0.698B 0.00
LeMaitre Vascular (LMAT) United States $0.572B 27.71
Surmodics (SRDX) United States $0.543B 78.88
OraSure Technologies (OSUR) United States $0.531B 24.43
Meridian Bioscience (VIVO) United States $0.476B 14.56
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.404B 0.00
Vapotherm (VAPO) United States $0.345B 0.00
Utah Medical Products (UTMD) United States $0.320B 22.13
BioLife Solutions (BLFS) United States $0.304B 95.24
Zynex (ZYXI) United States $0.250B 25.67
Bovie Medical (APYX) United States $0.236B 0.00
Cytosorbents (CTSO) United States $0.227B 0.00
Owens & Minor (OMI) United States $0.198B 4.20
Chimerix (CMRX) United States $0.188B 0.00
United Health Products (UEEC) United States $0.175B 0.00
Rockwell Medical (RMTI) United States $0.170B 0.00
Female Health (VERU) United States $0.146B 0.00
Fonar (FONR) United States $0.139B 7.33
Chembio Diagnostics (CEMI) United States $0.098B 0.00
United-Guardian (UG) United States $0.094B 20.65
InfuSystems Holdings (INFU) United States $0.090B 0.00
Surface Oncology (SURF) United States $0.075B 0.00
Trinity Biotech (TRIB) Ireland $0.060B 20.75
Oramed Pharmaceuticals (ORMP) United States $0.058B 0.00
MRI INTERVENTNS (MRIC) United States $0.052B 0.00